Endothelium and bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 277-280

  Catani, L ^a   Gugliotta, L ^a,b   Vianelli, N ^a   Nocentini, F ^a   Baravelli, S ^a   Bandini, G ^a   Cirio, T M ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

BMT; Endothelium; P selectin; Thrombomodulin; VOD

Indexed keywords

ALTEPLASE; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; MELPHALAN; PADGEM PROTEIN; THROMBOMODULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEMBRANE DAMAGE; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; THROMBOSIS; VASCULAR ENDOTHELIUM; VEIN OCCLUSION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; ENDOTHELIUM, VASCULAR; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; P-SELECTIN; THROMBOMODULIN; THROMBOSIS;

EID: 0030022544     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.
2. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive disease after radiation. Arch Path Lab Med 1980: 104: 584-588.
3. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024-2029.
4. Wada H, Ohiwa M, Kaneko T et al. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 1992: 39: 220-224.
5. Takahashi H, Ito S. Hanano M et al. Circulating thrombomodulin as a novel endothelial cell marker comparison of its behaviour with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol 1992; 41: 32-39.
6. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-2182.
7. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 6118-6125.
8. Chong BH, Murray B, Berndt MC et al. Plasma P-Selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83: 1535-1539.
9. Jones RJ, Lee KS, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783.
10. Kumada T, Dittman WA, Majerus PW. A role for thrombomodulin in the pathogenesis of thrombin induced thromboembolism in mice. Blood 1987; 71: 728-733.
11. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
12. Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol 1992; 10: 411-452.
13. Gugliotta L, Catani L, Vianelli N et al. High plasma levels of TNF-alpha may be predictive of VOD occurrence in BMT. Blood 1994; 83: 2385-2386 (letter).
14. Catani L, Gugliotta L, Mattioli Belmonte M et al. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies. Bone Marrow Transplant 1993; 12: 253-259.
15. Faioni EM, Bearman SI, Krachmalnicoff A et al. Procoagulant imbalance due to low levels of protein C in patients with venoocclusive disease (VOD) of the liver after marrow transplantation. Blood 1991; 78: 193a.